| Recruiting | Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chroni NCT07352800 | Aplagon Oy | Phase 2 |
| Not Yet Recruiting | Wearable Devices Assist in the Detection, Screening, and Management of Major Diseases in Middle-aged and Elder NCT06980064 | Tongji Hospital | N/A |
| Recruiting | VITUS Post-Market Registry NCT06832631 | OrbusNeich | — |
| Completed | Medium-term Results of Lower Limb Arterial Bypass NCT07093632 | Hospices Civils de Lyon | — |
| Recruiting | Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Arte NCT06319339 | University of Nebraska | EARLY_Phase 1 |
| Recruiting | Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteer NCT06204237 | Aplagon Oy | EARLY_Phase 1 |
| Recruiting | RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients NCT05961943 | National Institute for Prevention and Cardiovascular Health, Ireland | N/A |
| Withdrawn | The SIR-POBA Bypass Trial NCT06056193 | Paracelsus Medical University | N/A |
| Recruiting | FRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial NCT06082466 | Paracelsus Medical University | N/A |
| Recruiting | Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis. NCT05933720 | Ryazan State Medical University | N/A |
| Unknown | The EasyFlype/EasyHiFlype Post Market Clinical Follow-up Study. NCT05616169 | CID S.p.A. | — |
| Withdrawn | Prospective Study of the SoundBite™ Crossing System in Complex Peripheral CTOs NCT03933657 | SoundBite Medical Solutions, Inc. | N/A |
| Unknown | Risk Factors for Adverse Outcomes of Endovascular Revascularization in Lower Extremity Arteriosclerosis Occlus NCT05586022 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Unknown | Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD) NCT04083755 | Biobizkaia Health Research Institute | Phase 4 |
| Terminated | The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions NCT04007055 | Marissa Jarosinski | Phase 3 |
| Unknown | The VaSecure BTK Study NCT03638115 | Vascuros Medical Pte Ltd | N/A |
| Unknown | Lifestyle Modification Programme for Patients With Peripheral Arterial Disease NCT03935776 | Western Vascular Institute, Ireland | N/A |
| Terminated | Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD NCT03339973 | RHEACELL GmbH & Co. KG | Phase 1 / Phase 2 |
| Completed | CO2-Angiography-Study to Evaluate Diagnostic and Safety to Patients With Peripher Arterial Stenotic or Occlusi NCT05590182 | Jena University Hospital | N/A |
| Withdrawn | Autologous BMMNC Combined With HA Therapy for PAOD NCT03214887 | Academia Sinica, Taiwan | Phase 1 / Phase 2 |
| Unknown | Evaluate the Correlation of NIRS, ABI, Exercise, baPWV and Albuminuria With Peripheral Artery Occlusion Diseas NCT03378024 | Chang Gung Memorial Hospital | — |
| Completed | Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Clau NCT02832570 | University Hospital, Angers | Phase 3 |
| Completed | The Effect of Remifentanil-dexmedetomidine Compared With Remifentanil-midazolam on Patient's Satisfaction NCT02929095 | Yonsei University | N/A |
| Completed | "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (LOCOMOTIVE Exten NCT02900274 | B. Braun Melsungen AG | — |
| Completed | Venous Distension in Patients With Aneurysmatic Arterial Disease NCT02867501 | Kantonsspital Baselland Bruderholz | — |
| Completed | "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes NCT02531230 | B. Braun Melsungen AG | — |
| Active Not Recruiting | Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wi NCT02460042 | B. Braun Melsungen AG | — |
| Completed | Activity To Improve Outcomes in Peripheral Arterial Disease NCT02189018 | Baltimore VA Medical Center | N/A |
| Withdrawn | Surgical Revascularisation and Nerve Stimulation Trial NCT01938924 | Hull University Teaching Hospitals NHS Trust | N/A |
| Completed | Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes NCT01855412 | Abbott Medical Devices | — |
| Completed | Interest of a Bi-truncal Nerve Block (Femoral + Sciatic) Extended, Systematically Associated With General Anes NCT01785693 | University Hospital, Clermont-Ferrand | Phase 4 |
| Unknown | The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation NCT01774058 | Prim PD Dr Afshin Assadian | Phase 2 |
| Completed | Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial NCT01654471 | Seoul National University Hospital | — |
| Terminated | The ABSORB BTK (Below The Knee) Clinical Investigation NCT01341340 | Abbott Medical Devices | N/A |
| Completed | Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials NCT01135797 | Sanofi | — |
| Completed | Study Comparing Synthetic Vascular Grafts in Patients With Peripheral Artery Disease (PAD) Who Require Artery NCT01113892 | Maquet Cardiovascular | N/A |
| Completed | Isovue in Peripheral Digital Subtraction Angiography (DSA) NCT01075217 | Bracco Diagnostics, Inc | Phase 4 |
| Completed | Troponin T as Risk Stratification Tool in Peripheral Arterial Occlusive Disease NCT01087385 | University Heart Center Freiburg - Bad Krozingen | — |
| Withdrawn | Ovine Graft (Omniflow II) Versus PTFE in Below Knee Arterial Reconstruction NCT00845585 | Insel Gruppe AG, University Hospital Bern | N/A |
| Completed | Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA NCT00740207 | Bracco Diagnostics, Inc | Phase 4 |
| Terminated | EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study NCT00718991 | Flanders Medical Research Program | Phase 2 / Phase 3 |
| Terminated | Vasovist Magnetic Resonance Angiography (MRA) in Peripheral Arterial Occlusive Disease NCT00717639 | Heidelberg University | Phase 4 |
| Completed | FeMoropopliteal AngioSculpt™ SCoring BallOon CaTheter Study NCT00619788 | Flanders Medical Research Program | Phase 2 / Phase 3 |
| Terminated | GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft NCT00617279 | W.L.Gore & Associates | Phase 4 |
| Completed | Cryoplasty CLIMB-registry NCT00459888 | Flanders Medical Research Program | Phase 4 |
| Unknown | Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia NCT00434616 | Franziskus-Krankenhaus | Phase 2 / Phase 3 |
| Completed | The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation NCT01682889 | Medical Scientific Fund of the Mayor of Vienna | Phase 4 |
| Suspended | ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional NCT00593762 | Johann Wolfgang Goethe University Hospital | — |
| Unknown | Remote Endarterectomy Versus Suprageniculate Femoropopliteal Bypass NCT00566436 | St. Antonius Hospital | N/A |
| Completed | Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication NCT01157871 | Sanofi | Phase 2 |
| Completed | Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV NCT00596752 | UCB BIOSCIENCES GmbH | Phase 4 |
| Unknown | Early Detection of Arteriosclerosis NCT00863967 | Kantonsspital Baselland Bruderholz | — |
| Completed | Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned NCT01157143 | Sanofi | Phase 1 |
| Completed | Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease NCT01157156 | Sanofi | Phase 1 |
| Withdrawn | Efficacy of Sildenafil on the Morbi-mortality of Peripheral Arterial Diseased Patients With Intermittent Claud NCT02930811 | University Hospital, Angers | Phase 3 |